Iltumur Kenan, Karabulut Aziz, Toprak Gülten, Toprak Nizamettin
Department of Cardiology, Faculty of Medicine, Dicle University, 21280 Diyarbakýr, Turkey.
APMIS. 2005 Mar;113(3):167-74. doi: 10.1111/j.1600-0463.2005.apm1130303.x.
The complement system is part of the host defence response. However, considerable evidence suggests that complement plays an important role in the pathophysiology of ischemic heart disease. The aim of this study was to evaluate complement activation in patients with all forms of acute coronary syndromes (ACS) and to examine the relationship between the degree of complement activation and myocardial injury. The study population included 152 subjects (26 females): 82 with ACS (35 acute myocardial infarction (AMI), 22 non-Q wave MI (NQMI), 25 unstable angina (UAP)) (Group A), 35 stable angina (SA) (Group B), and 35 healty control subjects (Group C). Complement 3 (C3), Complement 4 (C4), C-reactive protein (CRP), troponin I (TnI) as well as creatine kinase MB (CK-MB) were evaluated. Patients' blood samples were taken on admission (day 1) and after 2, 3 and 7 days in group A. However, only one measurement was performed in the groups B and C. Plasma C3 and C4 peak levels were significantly higher in patients with AMI (141+/-29 and 35+/-11 mg/dl) and NQMI (136+/-13 and 35+/-7 mg/dl) than in patients with SA (128+/-14 and 27+/-10 mg/dl) and the control subjects (114+/-22 and 22+/-7 mg/dl) (p<0.03). Also, C3 and C4 serum levels in patients with SA and UAP (126+/-16 and 31+/-7 mg/dl) were significantly higher than those in control subjects (p<0.01, p<0.03, respectively). At 1-week follow-up, there were no significant differences between the plasma levels of C3 and C4 in patients with UAP (p>0.05). However, plasma levels of C3 and C4 were significantly different between days in patients with AMI and NQMI (p<0.0001). Plasma C3 and C4 levels in ACS showed a relationship with peak CK-MB and Tn I levels (p<0.01). Plasma CRP level in ACS showed positive correlation with C3 (p<0.01) and C4 (p<0.001). In this study, we determined that plasma C3 and C4 levels were elevated in ACS and SA. Although C3 and C4 were higher in ACS and SA, the systemic levels of inflammatory markers in patients with SA and UAP were lower than those found in the AMI and NQMI groups. The relationship between C3, C4 levels and ACS further suggests that the complement activation is related to necrosis within the myocardium.
补体系统是宿主防御反应的一部分。然而,大量证据表明补体在缺血性心脏病的病理生理学中起重要作用。本研究的目的是评估各种形式急性冠脉综合征(ACS)患者的补体激活情况,并研究补体激活程度与心肌损伤之间的关系。研究人群包括152名受试者(26名女性):82例ACS患者(35例急性心肌梗死(AMI)、22例非Q波心肌梗死(NQMI)、25例不稳定型心绞痛(UAP))(A组),35例稳定型心绞痛(SA)患者(B组),以及35名健康对照者(C组)。评估了补体3(C3)、补体4(C4)、C反应蛋白(CRP)、肌钙蛋白I(TnI)以及肌酸激酶MB(CK-MB)。A组患者在入院时(第1天)以及入院后第2、3和7天采集血样。然而,B组和C组仅进行了一次测量。AMI患者(141±29和35±11mg/dl)和NQMI患者(136±13和35±7mg/dl)的血浆C3和C4峰值水平显著高于SA患者(128±14和27±10mg/dl)和对照者(114±22和22±7mg/dl)(p<0.03)。此外,SA和UAP患者(126±16和31±7mg/dl)的C3和C4血清水平显著高于对照者(分别为p<0.01,p<0.03)。在1周随访时,UAP患者的血浆C3和C4水平之间无显著差异(p>0.05)。然而,AMI和NQMI患者在不同天数的血浆C3和C4水平存在显著差异(p<0.0001)。ACS患者的血浆C3和C4水平与CK-MB和TnI峰值水平相关(p<0.01)。ACS患者的血浆CRP水平与C3(p<0.01)和C4(p<0.001)呈正相关。在本研究中,我们确定ACS和SA患者的血浆C3和C4水平升高。尽管ACS和SA患者的C3和C4水平较高,但SA和UAP患者的全身炎症标志物水平低于AMI和NQMI组。C3、C4水平与ACS之间的关系进一步表明补体激活与心肌内坏死有关。